Corporate Accountability

How the Supreme Court Could Delay Any Health Care Chaos

By Tony Mauro

 

…Though it was a practical solution, the stay in Northern Pipeline seemed contradictory at the time—allowing an unconstitutional system to persist, even for a few months. King v. Burwell is a statutory, not a constitutional case. If the court rules against the administration and then stays its decision, the ruling could raise constitutional and practical concerns, according to Elizabeth Wydra, chief counsel of the Constitutional Accountability Center, who filed a brief in the case on behalf of legislators supporting the Obama administration. 

 

“Even if the court took the extremely unusual step of delaying the effect of its ruling and sidestepped the constitutional concerns about continuing to permit money to flow out of the Treasury when the congressional authorization for that outlay has been invalidated,” Wydra said, “there is no guarantee that the political process would work to restore the tax credits.“….

More from Corporate Accountability

Corporate Accountability
September 9, 2025

ENFORCEMENT ACTIONS—Fifth Circuit rejects petition challenging OCC authority to enforce national banking rules

Wolters Kluwer VitalLaw
The court distinguished the national banking regulatory regime from the SEC’s antifraud provision in Jarkesy and the...
Corporate Accountability
July 11, 2025

This Group’s Record in Front of the Roberts Court Is Mind-Boggling

Slate
In a provocative dissenting opinion, Justice Ketanji Brown Jackson recently called out her colleagues on the Supreme Court...
By: Ana Builes, Brian R. Frazelle
Corporate Accountability
July 2, 2025

Moneyed Interests Still Prevail at the Supreme Court (2024-2025 Term)

The Court Continues to Favor Corporations over Workers, Consumers, and the Environment.
By: Brian R. Frazelle, Ana Builes
Corporate Accountability
U.S. Court of Appeals for the Third Circuit

Novartis v. Secretary United States Department of Health and Human Services

In Novartis v. Secretary United States Department of Health and Human Services, the United States Court of Appeals for the Third Circuit considered whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional...
Corporate Accountability
January 28, 2025

Federal Deposit Insurance as Jarkesy Waiver

Yale Journal on Regulation
An argument lurking just beneath the surface in a pending Fifth Circuit case could stem...
Corporate Accountability
U.S. Court of Appeals for the Second Circuit

Boehringer Ingelheim v. Department of Health and Human Services

In Boehringer Ingelheim v. Department of Health and Human Services, the United States Court of Appeals for the Second Circuit considered whether the Inflation Reduction Act’s Medicare drug price negotiation program is an unconstitutional taking...